Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors
暂无分享,去创建一个
T. Cihlar | Tomas Cihlar | G. Birkuš | Gabriel Birkus | Michael J. M. Hitchcock | M. Hitchcock | T. Cihlář
[1] T. Cihlar,et al. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. , 2002, Antiviral research.
[2] J. Kahn,et al. Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults , 2001, Antimicrobial Agents and Chemotherapy.
[3] T. Cihlar,et al. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, 20(4–7), 641–648 (2001) HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGS , 2003 .
[4] C. Perry,et al. Abacavir , 2000, Drugs.
[5] G. Moyle. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. , 2000, Clinical therapeutics.
[6] K. Miller,et al. Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases , 2000, Annals of Internal Medicine.
[7] F. Authier,et al. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits , 2000, Acta Neuropathologica.
[8] T. Kakuda,et al. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.
[9] V. Darley-Usmar,et al. Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells , 2000, Antimicrobial Agents and Chemotherapy.
[10] M. Magnani,et al. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine. , 1999, The Biochemical journal.
[11] I. Nelson,et al. A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. , 1999, American journal of human genetics.
[12] N. Chandel,et al. Cells depleted of mitochondrial DNA (p0) yield insight into physiological mechanisms , 1999, FEBS letters.
[13] J. Sastre,et al. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver , 1999, Hepatology.
[14] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.
[15] J. Sastre,et al. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. , 1998, The Journal of clinical investigation.
[16] L. Nijtmans,et al. Assembly of cytochrome-c oxidase in cultured human cells. , 1998, European journal of biochemistry.
[17] B. Robbins,et al. Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9-R-(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA , 1998, Antimicrobial Agents and Chemotherapy.
[18] J. L. Smith,et al. Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. , 1997, Biochimica et biophysica acta.
[19] J. Shapiro,et al. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. , 1997, Critical care medicine.
[20] G. Barlovatz-Meimon,et al. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells , 1997, Journal of the Neurological Sciences.
[21] T. Cihlar,et al. Incorporation of Selected Nucleoside Phosphonates and Anti-Human Immunodeficiency Virus Nucleotide Analogues into DNA by Human DNA Polymerases α, β and γ , 1997 .
[22] W. Parker,et al. Lack of mitochondrial toxicity in CEM cells treated with carbovir. , 1997, Antiviral research.
[23] C. Perry,et al. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. , 1997, Drugs.
[24] J. Sommadossi,et al. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. , 1997, The Journal of pharmacology and experimental therapeutics.
[25] R. Schinazi,et al. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity. , 1996, Biochemical pharmacology.
[26] S. Eriksson,et al. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity , 1996, Antimicrobial agents and chemotherapy.
[27] E. Levine,et al. Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. O. Poyton,et al. Crosstalk between nuclear and mitochondrial genomes. , 1996, Annual review of biochemistry.
[29] H. Conjeevaram,et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.
[30] J. Cherrington,et al. Kinetic Interaction of the Diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and Other anti-HIV Active Purine Congeners with HIV Reverse Transcriptase and Human DNA Polymerases α, β and γ , 1995 .
[31] M. Dalakas,et al. Mitochondrial toxicity of antiviral drugs , 1995, Nature Medicine.
[32] R. Schinazi,et al. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. , 1995, The Journal of clinical investigation.
[33] J. Simpson,et al. Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU Triphosphate. , 1994, Biochemistry.
[34] J. L. Martin,et al. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis , 1994, Antimicrobial Agents and Chemotherapy.
[35] C. Tsai,et al. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides , 1994, Antimicrobial Agents and Chemotherapy.
[36] M. Chevallier,et al. Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy , 1994, Journal of internal medicine.
[37] T. Sprinkle,et al. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[38] William,et al. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. , 1992, The Journal of clinical investigation.
[39] J. A. Freedman,et al. Cytochrome c oxidase: structure, function, and membrane topology of the polypeptide subunits. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[40] W. Grody,et al. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[41] C. H. Chen,et al. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.
[42] S. Dimauro,et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.
[43] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[44] K. E. Follis,et al. Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2 , 1989, Antimicrobial Agents and Chemotherapy.
[45] M. Dalakas,et al. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc) , 1989, Muscle & nerve.